Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group
- PMID: 8695235
- DOI: 10.1016/0959-8049(95)00473-4
Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical